Financials
- Fiscal year
- 2024
- Turnover
- €2.4m
- Profit
- €278,380
- Solvency
- 95.7%
Turnover▼ 28.6%
Net result
20232024
ALPHADENT
ActiveSummary
ALPHADENT has been active since 1975 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €7.5m and a net result of €278,380. Equity is growing by ~2.6% per year across the filed fiscal years. Its solvency ranks better than 95% of 9085 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Activity
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
1 site
Size
€2.4mturnover 2024
- Staff
- 4 FTE
- Equity
- €7.5m
- Profit
- €278,380
Net result +201%: other schema
Structure
- Parent
- ARSEUS LAB · 99.98%
Accounts 6 d early0 of 26 deeds read
Why 96- Figures for FY 2024 (filed 22-07-2025)+ Founded in 1975+ Liquidity: current ratio 26.99, cash €7.5m+ Equity €7.5m (95.7% of total assets)Show the evidence
Checked score
Score 2024
96
/ 100
Excellent
Probability in this band: under 0.55%
Better than 67% of its sector peers (NACE 46, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2023
Strong
Solvency
100=
equity 95.7% of total assets
Liquidity
100=
short-term debt 3.7% · cash 96.2%
Profitability
63+46
return on assets 3.6%
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 11 months
12-2025: < 0.1%
01-2026: < 0.1%▼ -3.3% vs 12-2025
02-2026: < 0.1%● 0.0% vs 01-2026
03-2026: < 0.1%● 0.0% vs 02-2026
04-2026: < 0.1%▼ -3.4% vs 03-2026lowest value
05-2026: < 0.1%▲ +3.6% vs 04-2026
06-2026: < 0.1%● 0.0% vs 05-2026
07-2026: < 0.1%▲ +6.9% vs 06-2026
08-2026: < 0.1%▲ +35.5% vs 07-2026
09-2026: < 0.1%▲ +9.5% vs 08-2026
10-2026: 0.1%▲ +60.9% vs 09-2026highest value
- Figures for FY 2024 (filed 22-07-2025) raises the probability
- Founded in 1975 lowers the probability for this profile
- Liquidity: current ratio 26.99, cash €7.5m lowers the probability
- Equity €7.5m (95.7% of total assets) lowers the probability
Credit up to €230,000 at 30 days acceptable
Liquidity ample (current ratio 26.99 against 13.07 in 2023; short-term debt: 3.7% and cash: 96.2% of total assets), and 4.3% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, micro). Better than this share of them on solvency 90%, liquidity 98%, profitability 46%, growth against the median 34%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
neutral · Latest accounts filed on time
The financial year that closed on 28-12-2024 was due by 28-07-2025 and was filed on 22-07-2025, 6 days ahead of the deadline.
NBB · 9 filingsDeviation from the deadline
2024
6 d early
2023
48 d early
2022
40 d early
2021
39 d early
2020
31 d early
2019
33 d early
2018
32 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 33 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · abbreviated…
- Annual accounts filedfiscal year 2023 · full…
- Liquidity doublescurrent ratio 26.99
Key points
- Positive: Result rose in 2024different schema filed ▲ 201% View
- Positive: Among the best 5% on solvencysector median 44.1% · 9,085 companies 95.7% View
- Positive: Always filed on timeaccounts within the deadline every year 8 years View
- Controlled by ARSEUS LAB 99.98% View
- Positive: 7 profitable years in a rowprofit 2024: €278,380 7 years View
- Active since 1975founded 27-01-1975 51 years View
By topic
Board & ownership
- Parent
- ARSEUS LAB · 99.98%
Timeline
- Events
- 12
- Since
- 2017
- 22-07-2025Annual accounts filed
- 23-01-2025Annual accounts filed
- 28-12-2024Liquidity doubles
Company details
- Sites
- 1
- Legal form
- Public limited company
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Founded
- 27-01-1975
- Year ends
- 28-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.